2010
DOI: 10.3892/mmr.2010.365
|View full text |Cite
|
Sign up to set email alerts
|

Mammalian target of the rapamycin pathway is involved in non-alcoholic fatty liver disease

Abstract: Abstract. non-alcoholic fatty liver disease (naFld) is a common liver disease associated with an increased risk of type 2 diabetes and cardiovascular disease. Many factors may contribute to naFld development and progression, but the exact mechanisms are still not fully understood. in this study, Sprague-dawley rats were fed either a standard diet (control group), a high-fat diet for 8 weeks (the HFd-8 group) or a high-fat diet for 16 weeks (the HFd-16 group). The HFd animals showed high levels of aspartate ami… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 22 publications
(24 reference statements)
0
15
1
Order By: Relevance
“…When we analyzed these data using Ingenuity Pathway Analysis, several of the top pathways were linked to mTOR signaling (Table ). We found this intriguing, as although few reports have linked mTOR signaling directly to hepatic steatosis, mTOR signaling seemed an interesting pathway for steatosis and NASH, as mTOR clearly has an important role in several processes regulating cell growth and metabolism such as lipogenesis, protein translation, and autophagy . This led us to investigate the role of mTOR and Torc1 in our fructose‐induced model of hepatic steatosis in zebrafish larvae.…”
Section: Resultsmentioning
confidence: 85%
“…When we analyzed these data using Ingenuity Pathway Analysis, several of the top pathways were linked to mTOR signaling (Table ). We found this intriguing, as although few reports have linked mTOR signaling directly to hepatic steatosis, mTOR signaling seemed an interesting pathway for steatosis and NASH, as mTOR clearly has an important role in several processes regulating cell growth and metabolism such as lipogenesis, protein translation, and autophagy . This led us to investigate the role of mTOR and Torc1 in our fructose‐induced model of hepatic steatosis in zebrafish larvae.…”
Section: Resultsmentioning
confidence: 85%
“…Treating the mice with 3-maleimidopropionic acid or silencing the ATG5 gene with siRNA sharply increased the accumulation of lipid droplets in liver cells. Furthermore, rapamycin (mTOR inhibitor) was found to promote autophagy and also to alleviate lipid deposition both in vivo and in vitro [31]. Pretreatment with rapamycin (25 ng/mL) resulted in increased autophagy, while the levels of ER stress, apoptosis and lipid droplets decreased in palmitic acid-induced fatty hepatocytes[32].…”
Section: Nafld and Autophagymentioning
confidence: 99%
“…In addition, decreased activity of liver S6K1 [94], IKK β , and JNK1 [95] improves hepatic insulin sensitivity. Reciprocally, S6K1 activation in fat-fed mouse liver or specific activation of hepatic ERK1 by C-reactive protein is linked to steatosis and insulin resistance [96, 97]. These stress kinases are targets of PP2A [98100], a redox-sensitive protein phosphatase inactivated in an oxidized environment.…”
mentioning
confidence: 99%